Millions of disabled people and seniors worldwide suffering from impaired walking, are confined to a sedentary lifestyle in a wheelchair, causing health deterioration, poor quality of life, and high medical expenses – a burden for the disabled, their families and health insurers. Numerous studies have demonstrated the physical and mental health benefits of wheelchairs with a standing position, which enables users to mobilize body parts, and reduce falls when reaching for high objects.
As the number of wheelchair and scooter users grows, due to both increasing accidents and aging populations, many seek a smart mobility device that will provide fully-functional standing and sitting mobility, improve health, enhance social inclusion, and reduce healthcare and living expenses.
UPnRIDE is a wheeled robotic device, providing upright and seated mobility both for wheelchair users, and for anyone who is unable to, or has difficulty standing or walking.
UPnRIDE offers numerous medical, psychological, and economic benefits, ensuring safety while standing, sitting, and shifting between positions, in practically any urban Environment.
Product Information is available from UPnRIDE Website.
Ekso Bionics , a robotic exoskeleton company, announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Ekso GT robotic exoskeleton for use in the treatment of individuals with hemiplegia due to stroke, individuals with spinal cord injuries at levels T4 to L5, and individuals with spinal cord injuries at levels of T3 to C7 (ASIA D), in accordance with device’s labeling. The Ekso GT is the first exoskeleton cleared by the FDA for use with stroke patients.
After receiving CE mark in late 2015, Parker Hannifin announced that FDA has also cleared Indego Exoskeleton for clinic and personal use.
Indego is a robotic exoskeleton or powered orthotic device that allows users to stand and walk and holds great promise for affording people with paraplegia a new level of independence. “For individuals who sustain spinal cord injuries, this is a milestone that could have a meaningful impact on their lives,” said Tom Williams, chairman and CEO of Parker Hannifin.
Indego system is now available in European market, Parker Hannifin plans to offer the device in USA market as well in a few months.
Please go to Indego product page by clicking this link.
Further news: FDA Cleared Robotic Exoskeleton for Patients from Stroke & Spinal Cord Injury